Insider Trading disclosures for Mind Medicine Inc

The latest disclosure was made by Carrie F. Liao in Mind Medicine Inc where a trade of 2,347 Common Shares done at an average price of $6.7 was reported to US exchanges on March 25, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Carrie F. Liao	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 6.74 per share.	25 Mar 2025	2,347	144,923	-	6.7	15,819	Common Shares
Dan Karlin	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 6.74 per share.	25 Mar 2025	6,836	446,177	-	6.7	46,075	Common Shares
Robert B. Barrow	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.74 per share.	25 Mar 2025	21,208	856,556	-	6.7	142,942	Common Shares
Mark R. Sullivan	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 6.74 per share.	25 Mar 2025	6,576	316,621	-	6.7	44,322	Common Shares
Carrie F. Liao	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2025	50,000	142,270	-		0	Common Shares
Dan Karlin	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2025	115,000	453,013	-		0	Common Shares
Robert B. Barrow	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2025	350,000	877,764	-		0	Common Shares
Mark R. Sullivan	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2025	150,000	323,197	-		0	Common Shares
Dan Karlin	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 7.43 per share.	26 Dec 2024	6,643	338,013	-	7.4	49,357	Common Shares
Sullivan Mark R.	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 7.43 per share.	26 Dec 2024	4,519	173,197	-	7.4	33,576	Common Shares
B. Robert Barrow	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.43 per share.	26 Dec 2024	19,106	526,666	-	7.4	141,958	Common Shares
F. Carrie Liao	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 7.43 per share.	26 Dec 2024	2,273	97,270	-	7.4	16,888	Common Shares
W. David Gryska	Director	Purchase of securities on an exchange or from another person at price $ 7.17 per share.	05 Dec 2024	2,500	19,851	-	7.2	17,925	Common Shares
Carrie F. Liao	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 5.98 per share.	25 Sep 2024	2,352	99,543	-	6.0	14,065	Common Shares
Dan Karlin	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 5.98 per share.	25 Sep 2024	6,871	344,656	-	6.0	41,089	Common Shares
Robert B. Barrow	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 5.98 per share.	25 Sep 2024	19,771	545,772	-	6.0	118,231	Common Shares
Mark R. Sullivan	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 5.98 per share.	25 Sep 2024	4,430	177,716	-	6.0	26,491	Common Shares
David W. Gryska	Director	Purchase of securities on an exchange or from another person at price $ 5.98 per share.	23 Aug 2024	3,500	17,351	-	6.0	20,930	Common Shares
Miri Halperin Wernli	Executive President		21 Aug 2024	32,595	202,405	-	6.2	201,111	Common Shares
Miri Halperin Wernli	Executive President		21 Aug 2024	50,000	235,000	-	3.7	185,000	Common Shares
Miri Halperin Wernli	Executive President		21 Aug 2024	50,000	0	-		-	Stock Option (Right to Buy)
Robert B. Barrow	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 6.31 per share.	19 Aug 2024	500	565,043	-	6.3	3,155	Common Shares
Robert B. Barrow	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 6.12 per share.	19 Aug 2024	500	565,543	-	6.1	3,060	Common Shares
Dan Karlin	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 7.22 per share.	25 Jun 2024	6,925	351,527	-	7.2	49,999	Common Shares
Robert B. Barrow	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 7.22 per share.	25 Jun 2024	15,659	564,543	-	7.2	113,058	Common Shares
Mark R. Sullivan	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 7.22 per share.	25 Jun 2024	17,854	182,146	-	7.2	128,906	Common Shares
David W. Gryska	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2024	16,506	16,506	-		-	Stock Option (Right to Buy)
Andreas Krebs	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2024	16,506	16,506	-		-	Stock Option (Right to Buy)
Carol A. Vallone	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2024	16,506	16,506	-		-	Stock Option (Right to Buy)
Roger Crystal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2024	16,506	16,506	-		-	Stock Option (Right to Buy)
Suzanne L. Bruhn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2024	16,506	16,506	-		-	Stock Option (Right to Buy)
Dan Karlin	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 9.50 per share.	25 Mar 2024	6,578	358,452	-	9.5	62,491	Common Shares
Robert B. Barrow	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 9.50 per share.	25 Mar 2024	16,519	580,202	-	9.5	156,931	Common Shares
Schond L. Greenway	Chief Financial Officer		25 Mar 2024	5,560	211,057	-	9.8	54,377	Common Shares
Carrie Liao F.	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	100,000	100,000	-		-	Stock Option (Right to Buy)
Mark R. Sullivan	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	125,000	125,000	-		-	Stock Option (Right to Buy)
Wernli Miri Halperin	Executive President		27 Feb 2024	125,000	125,000	-		-	Stock Option (Right to Buy)
Greenway L. Schond	Chief Financial Officer		27 Feb 2024	150,000	150,000	-		-	Stock Option (Right to Buy)
Dan Karlin	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	150,000	150,000	-		-	Stock Option (Right to Buy)
Robert B. Barrow	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2024	400,000	400,000	-		-	Stock Option (Right to Buy)

Showing 1 to 40 of 40 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low in past week

Insider Trading disclosures for Mind Medicine Inc

The latest disclosure was made by Carrie F. Liao in Mind Medicine Inc where a trade of 2,347 Common Shares done at an average price of $6.7 was reported to US exchanges on March 25, 2025.

Screeners based on Insider Trading and SAST parameters